P002 Interleukin-8 (IL8) and transforming growth-factor beta (TGF-β) as drugable biomarkers of response, progression-free (PFS) and overall survival (OS) with pazopanib (PZP): A phase 2 study in relapsed urothelial cancer (UC)

✍ Scribed by Necchi, A.; Mariani, L.; Zaffaroni, N.; Giannatempo, P.; Nicolai, N.; Raggi, D.; Pennati, M.; Morosi, C.; Lanocita, R.; Crippa, F.; Daidone, M.G.; Gianni, A.M.; De Braud, F.; Salvioni, R.

• Book ID: 122059184
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 106 KB
• Volume: 11
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(13)60383-8